FSSNX | JCCIX | FSSNX / JCCIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 11 years | - |
Gain YTD | 20.289 | 17.411 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 26.9B | 2.2B | 1,224% |
Annual Yield % from dividends | 1.36 | 0.13 | 1,010% |
Returns for 1 year | 36.08 | 30.20 | 119% |
Returns for 3 years | 5.63 | -4.61 | -122% |
Returns for 5 years | 54.79 | 54.64 | 100% |
Returns for 10 years | 94.28 | 85.31 | 111% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASMNX | 25.00 | 0.48 | +1.96% |
AQR Small Cap Momentum Style N | |||
SSCYX | 7.22 | 0.11 | +1.55% |
Saratoga Small Capitalization A | |||
JNGLX | 76.02 | 0.72 | +0.96% |
Janus Henderson Global Life Sciences D | |||
RICIX | 10.03 | 0.02 | +0.20% |
T. Rowe Price Intl Disciplined Eq I | |||
SEQFX | 11.38 | N/A | N/A |
SEI Emerging Markets Equity Y (SIT) |